TWIST BIOSCIENCE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.54 USD | +1.48% |
|
+12.84% | -14.43% |
Chart calendar Twist Bioscience Corporation
640410603ef55.DA1f07_-k3vfSpRslJB9uZ151DRe9U5tbcJmj91YfPg.e2BvvNO7oy6KJ-c80t4bitA3nkIwjAYBLPow4ZMUH7l_PRqJi7z5K7ws8w~cf33336a7ddaf6e1a4911f704d17d32e
Upcoming events on Twist Bioscience Corporation
Past events on Twist Bioscience Corporation
| 12/03/2024 05:00 pm | Barclays Global Healthcare Conference |
| 05/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 08/02/2024 04:30 am | Advances in Genome Biology and Technology General Meeting - Emily M. Leproust |
| 08/02/2024 03:15 am | Advances in Genome Biology and Technology General Meeting - Development of a high-throughput NGS lib |
| 07/02/2024 12:00 am | Advances in Genome Biology and Technology General Meeting - Twist Pan-Cancer Reference Standards V2 |
| 06/02/2024 06:30 pm | Annual General Meeting |
| 02/02/2024 06:30 pm | Q1 2024 Earnings Call |
| 02/02/2024 06:00 pm | Q1 2024 Earnings Release |
| 09/01/2024 06:45 am | JPMorgan Healthcare Conference |
| 28/11/2023 06:00 pm | Evercore ISI HealthCONx Conference |
| 17/11/2023 06:30 pm | Q4 2023 Earnings Call |
| 17/11/2023 06:00 pm | Q4 2023 Earnings Release |
| 02/11/2023 08:30 pm | American Society of Human Genetics Meeting |
| 27/09/2023 09:45 pm | Goldman Sachs Global Sustainability Forum |
| 12/09/2023 10:55 pm | Baird Global Healthcare Conference |
| 16/08/2023 02:30 am | UBS Genomics 2.0 and MedTech Innovations Summit |
| 12/08/2023 | BIG Impact Conference |
| 04/08/2023 05:30 pm | Q3 2023 Earnings Call |
| 04/08/2023 05:00 pm | Q3 2023 Earnings Release |
| 14/06/2023 04:30 am | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54,4 52,7 3.11% | 90,1 80,3 12.14% | 132 131 1.16% | 204 203 0.17% | 245 242 1.48% | 293 |
|
EBITDA Million USD | Released Forecast Spread | -103 -95,7 -7.34% | -111 -126 11.83% | -144 -142 -1.17% | -218 -236 7.34% | -188 -195 3.69% | -151 |
|
EBIT Million USD | Released Forecast Spread | -109 -103 -5.61% | -118 -140 16.09% | -153 -152 -1% | -235 -251 6.48% | -217 -215 -1.19% | -188 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -107 -103 -3.96% | -140 -146 4.69% | -154 -152 -1.37% | -228 -251 9.1% | -203 -205 0.55% | -179 |
|
Net income Million USD | Released Forecast Spread | -108 -103 -4.13% | -140 -147 4.57% | -152 -151 -0.94% | -218 -240 9.15% | -205 -207 1.15% | -180 |
|
EPS USD | Released Forecast Spread | -3,92 -3,80 -3.13% | -3,57 -3,73 4.38% | -3,15 -3,15 0% | -4,04 -4,44 8.94% | -3,60 -3,77 4.48% | -3,08 |
| Announcement Date | 11/12/19 | 23/11/20 | 22/11/21 | 18/11/22 | 17/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 42,0 38,2 9.95% | 48,1 45,3 6.36% | 56,1 52,1 7.78% | 57,3 57,0 0.46% | 54,2 54,5 -0.42% | 60,2 56,6 6.34% | 63,7 60,7 5.03% | 66,9 63,5 5.51% | 71,5 67,6 5.78% | 70,8 | 73,9 | 77,3 | 83,6 | 83,8 |
|
EBITDA Million USD | Released Forecast Spread | -55,6 -52,0 -6.95% | -56,8 -62,0 8.33% | -56,7 -72,0 21.22% | -43,5 -55,2 21.24% | -52,3 -60,0 12.85% | -41,6 -43,6 4.56% | -38,8 -39,1 0.75% | -39,4 | -38,2 | -36,7 | ||||
|
EBIT Million USD | Released Forecast Spread | -58,8 -52,4 -12.09% | -60,8 -64,1 5.17% | -61,2 -71,4 14.37% | -56,9 -71,0 19.92% | -48,8 -63,0 22.6% | -62,8 -65,1 3.54% | -60,8 -64,6 5.89% | -50,1 -51,7 3% | -47,0 -47,3 0.64% | -49,6 | -47,1 | -43,7 | -38,1 | -43,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,0 -52,6 -6.36% | -60,8 -65,1 6.52% | -60,7 -74,0 18% | -50,8 -74,4 31.66% | -41,7 -61,6 32.22% | -58,5 -64,2 8.97% | -56,8 -65,7 13.6% | -46,5 -52,5 11.46% | -42,9 -46,2 7.08% | -48,4 | -47,1 | -45,0 | -43,3 | -42,3 |
|
Net income Million USD | Released Forecast Spread | -45,6 -52,4 13.01% | -60,7 -64,1 5.3% | -60,5 -71,2 14.98% | -51,1 -73,4 30.33% | -41,8 -60,9 31.33% | -59,2 -64,2 7.84% | -57,4 -65,1 11.84% | -46,2 -52,5 11.94% | -43,0 -46,6 7.76% | -48,7 | -47,3 | -45,0 | -43,4 | -43,1 |
|
EPS USD | Released Forecast Spread | -0,91 -1,03 11.98% | -1,13 -1,27 10.77% | -1,08 -1,31 17.81% | -0,91 -1,29 29.29% | -0,74 -1,10 32.75% | -1,04 -1,15 9.63% | -1,01 -1,14 11.6% | -0,81 -0,95 14.53% | -0,75 -0,78 3.61% | -0,82 | -0,78 | -0,73 | -0,62 | -0,74 |
| Announcement Date | 04/02/22 | 05/05/22 | 05/08/22 | 18/11/22 | 03/02/23 | 05/05/23 | 04/08/23 | 17/11/23 | 02/02/24 | - | - | - | - | - |
More events
Past sector events for Twist Bioscience Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TWST Stock
- Calendar Twist Bioscience Corporation
